Evidence map›Paper›PMID 40608527›Full record

ArticleThe British journal of radiology2025

Understanding global variation in breast cancer mortality.

Marwa M A Elbasheer, David Dodwell, Toral Gathani

Abstract read
In one paragraph

Article in The British journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marwa M A ElbasheerCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, United Kingdom.
David DodwellNuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, United Kingdom.
Toral GathaniCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, United Kingdom.ORCID 0000-0003-2837-1535

Funding

Cancer Research UKCancer Research UK Prevention and Population Research PRCPJT-Nov22/100007CR-UK C7852-A25447NDPHNHS Foundation TrustOxford University Hospitals
6 · The paper itself

Abstract

Breast cancer is an important global health challenge. Among women, it is the most commonly diagnosed cancer and the leading cause of cancer-related mortality. There are significant variations in the incidence and mortality rates globally with highest incidence and lowest mortality observed in more developed countries. The number of women diagnosed with breast cancer is projected to rise to ∼3 million annual cases by 2050 from ∼2 million in 2022, and the number of breast cancer-related deaths is projected to rise to over 1 million by 2050 from ∼660 000 in 2022. The largest increases in both incidence and mortality will be in less developed regions of the world. Over the last 40 years, significant gains have been made in reducing breast cancer mortality in more developed countries, but significant challenges remain in tackling the less favourable mortality rates in less developed countries. In this article, we discuss the global variation in breast cancer mortality rates. We used Sudan to present a case study of the devastating impact of conflict on cancer care.

Indexed as

Breast NeoplasmsGlobal HealthDeveloping CountriesFemaleHumansIncidencebreast cancercancer careconflictglobal healthmortality

Identifiers

PMID40608527
PMCPMC12377464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.